Log in
医药生物行业报告：从海外启示，看医疗反腐后板块性投资机会-中邮证券
English body is not available for this report yet; showing the Chinese version. View in Chinese
常见问题
- 这份报告主要研究什么？
- 《医药生物行业报告：从海外启示，看医疗反腐后板块性投资机会-中邮证券》主要讨论：从海外启示，看医疗反腐后板块性投资机会 从海外经验看，医疗反腐是长期、常态化举措，能够保护合法利益和促进产业健康发展 海外发达国家有较长的医疗反腐历史，从上世纪六十年代开始，德日美各国政府积极采取相…
- 报告来自哪个机构？何时发布？
- 来源机构：中邮证券，报告发布于 2023-12-24，篇幅约 18 页。
Copyright notice
This report is aggregated from publicly available internet sources. Copyright belongs to the original authors or rights holders. If you are a rights holder and believe content on this platform infringes your rights, please email copyright@ruishubaogao.com . We will remove the content promptly after verification.